Christopher J. Senner - 08 Jun 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Director
Signature
/s/ Caryn Gordon McDowell, Attorney-in-Fact for Christopher J. Senner
Issuer symbol
QNCX
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
4
Filing time
09 Jun 2022, 20:48:12 UTC
Previous filing
17 May 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +27,000 $0.000000 27,000 08 Jun 2022 Common Stock 27,000 $3.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the stock option shall vest in full on the one-year anniversary of the grant date of June 8, 2022.